In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

4th Cytokine-Based Drug Development Summit 2023

Jun 27, 2023 - 09:00 AM - Jun 29, 04:00 PM
Hanson Wade
Hilton Boston Logan Airport
One Hotel Drive,

ZIP: 02128
Phone: +16174554188

Ticket Price: USD 2899.00 - USD 4997.00

New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical and clinical efficacy data as more companies get additional funding to boost their pipelines.

Now's the time to join forces with key decision-makers including Sanofi, Moderna, Xencor, CytomX and more at the 4th Cytokine-Based Drug Development Summit, the only industry focused event exclusively addressing your discovery, translational and reverse translational challenges.

This meeting will equip you with the latest scientific insights to develop a cytokine drug with reduced toxicities, enabling you to dose at the right level and witness greater clinical benefit to patients.

With a focus on IL-2, IL-12, IL-7 and more across oncology, autoimmune and infectious diseases, learn new approaches to limiting toxicities, how to develop an accurate and reliable preclinical model, as well as lessons from clinical development to inform future design principles.

Tickets: https://go.evvnt.com/1561164-2?pid=1052
Brochure: https://go.evvnt.com/1561164-3?pid=1052

Conference Only - Drug Developer: USD 2899.00,
Conference + Pre - Conference Workshop Day - Drug Developer: USD 4097.00,
Conference Only - Service Provider: USD 3599.00,
Conference + Pre - Conference Workshop Day - Service Provider: USD 4997.00

Speaker Details

Alexandra Wolfarth, Senior Scientist, NeoImmuneTech Inc., Angus Sinclair, SVP Immuno-oncology Research, IGM Biosciences, Asaf Maoz, Clinical Fellow, Brigham and Women's - Dana Farber Cancer Institute, Byung Ha Lee, SVP and CSO, NeoImmuneTech Inc., Donald Shaffer, Head of Precision Cytokines and Cell Therapies, Sanofi, Erwan Le Scolan, Associate Director, CytomX Therapeutics, Eva Vanamee, Co-Founder, FusionBio, Inc., Genevieve Inchauspe, ImmunResQ Department Head, Transgene, Giovanni Abbadessa, Vice President and Head of Early Development and Oncology, Sanofi Genzyme, Giulio Paciotti, Chief Science Officer, CytImmune Sciences, Hilario Ramos, Head Of Immunology, Invenra Inc., Irena Adkins, Director Pharmacology, SOTIO, Jamie Spangler, Assistant Professor - Biomedical, Chemical and Biomolecular Engineering, Johns Hopkins, John Cini, Chief Scientific Officer and Co-Founder, Sonnet BioTherapeutics Inc., Joshua Heiber, Principal Scientist, Alkermes, Matthew Bernett, Senior Director, Protein Engineering, Xencor, Michael Abadier, Director - Translational Medicine Oncology, Moderna, Nicki Panoskaltsis, Professor in Personalised Therapeutics, Trinity College Dublin, Nicolas Poirier, CEO-CSO, OSE Immunotherapeutics, Nikolai Kley, Founder, President and Chief Executive Officer, Orionis Biosciences LLC, Omid Veiseh, Co-founder, Avenge Bio, Richard Kenney, Chief Medical Officer, Sonnet BioTherapeutics Inc., Sam Murphy, Chief Executive Officer, Salubris Biotherapeutics Inc., Sara Ferrando-Martinez, Principal Scientist, NeoImmuneTech Inc., Susan Richards, Vice President - Translational Medicine and Early Development, Sanofi

Event Categories
Keywords: conference , oncology


Events Calendar

28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 1


VIP Life Time Subscription to our Newsletters!